Source:http://linkedlifedata.com/resource/pubmed/id/10555107
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
16
|
pubmed:dateCreated |
1999-12-10
|
pubmed:abstractText |
Homozygosity for a 32-base pair deletion (delta32) within the CC-chemokine receptor 5 (CCR5) gene confers resistance to infection by R5-type HIV-1 isolates. To ascertain how CCR5delta32 heterozygosity influences the susceptibility of lymphocytes and macrophages to HIV-1 infection, peripheral blood lymphocytes (PBLs) and monocyte-derived macrophages (MDMs) from three HIV-1-uninfected CCR5delta32 heterozygous infants and three HIV-1-uninfected CCR5 wild-type homozygous infants were exposed to two R5-type primary isolates. HIV-1 infection was monitored by DNA-PCR and p24 antigen determination; CCR5 and CCR5delta32 transcripts were quantified by competitive reverse transcription-PCR. Wild-type homozygous MDMs and PBLs and heterozygous PBLs were infected by both viral isolates, albeit with different efficiencies, but heterozygous MDMs showed restriction to HIV-1 infection. Lower levels of CCR5 mRNA and protein expression were found in heterozygous versus wild-type homozygous MDMs and PBLs. Interestingly, wild-type homozygous MDMs showed higher levels of CCR5 mRNA expression compared with wild-type homozygous PBLs, while heterozygous MDMs had lower levels of CCR5 wild-type mRNA and a higher CCR5delta32/CCR5 mRNA ratio compared with heterozygous PBLs. These findings suggest that CCR5delta32 heterozygosity confers a different degree of protection against HIV-1 in PBLs and MDMs, depending on the ratio of wild-type and mutant CCR5 mRNA in the two cell types, and may delay virus spread in the host by preventing infection of monocytes and macrophages.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0889-2229
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1441-52
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10555107-Adult,
pubmed-meshheading:10555107-DNA, Viral,
pubmed-meshheading:10555107-Female,
pubmed-meshheading:10555107-Gene Deletion,
pubmed-meshheading:10555107-HIV Antigens,
pubmed-meshheading:10555107-HIV Core Protein p24,
pubmed-meshheading:10555107-HIV Infections,
pubmed-meshheading:10555107-HIV-1,
pubmed-meshheading:10555107-Heterozygote,
pubmed-meshheading:10555107-Humans,
pubmed-meshheading:10555107-Infant, Newborn,
pubmed-meshheading:10555107-Leukocytes, Mononuclear,
pubmed-meshheading:10555107-Macrophages,
pubmed-meshheading:10555107-Monocytes,
pubmed-meshheading:10555107-Polymerase Chain Reaction,
pubmed-meshheading:10555107-Receptors, CCR5,
pubmed-meshheading:10555107-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
1999
|
pubmed:articleTitle |
Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene.
|
pubmed:affiliation |
Department of Oncology and Surgical Sciences, AIDS Reference Center, University of Padova, Padua, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|